Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

By S. Werns. 2012

688 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/e9c178adc03c5c92e49075998622a638aaea8915

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. M. Drazner
4. Joseph A. Hill
5. J. Januzzi
6. C. Yancy
7. Véronique L. Roger
8. M. Gheorghiade

Citations in the corpus

• Pathological Ventricular Remodeling: Mechanisms: Part 1 of 2 (2013, background): “Synthetic mimetics of natriuretic peptides have been approved for the treatment of acute heart failure, although the largest study so far of nesiritide, a recombinant form of human B-type natriuretic peptide, failed to detect improvements in mortality or rehospitalization.(151)”
• 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. (2013, background): “In all patients with a recent or remote history of MI or ACS, statins should be used to prevent symptomatic HF and cardiovascular events (104, 349-354).”